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Abstract
Background: Adenosine Deaminase Activity (ADA) is a commonly used marker for the diagnosis of tuberculous pleural
effusion. There has been concern about its usefulness in immunocompromised patients, especially HIV positive patients
with very low CD4 counts. The objective of this study was to evaluate the sensitivity of ADA in pleural fluid in patients with
low CD4 counts.
Materials and Methods: This was a retrospective case control study. Medical files of patients with tuberculous pleuritis and
non-tuberculous pleuritis were reviewed. Clinical characteristics, CD4 cell counts in blood and biochemical markers in
pleural fluid, including ADA were recorded.
Results: One ninety seven tuberculous pleuritis and 40 non- tuberculous pleuritis patients were evaluated. Using the cut-off
value of 30 U/L, the overall sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of ADA was 94%,
95%, 19, and 0.06 respectively. The mean CD4 cell counts among TB pleuritis patients was 29 and 153 cells/microL in
patients with CD4 ,50 cells/microL and .50 cells/microL, (p,0.05) respectively. The corresponding mean ADA values for
these patients were 76 U/L and 72 U/L respectively (p.0.5). There was no correlation between ADA values and CD4 cell
counts (r =20.120, p= 0.369).
Conclusion: ADA analysis is a sensitive marker of tuberculous pleuritis even in HIV patients with very low CD4 counts in a
high TB endemic region. The ADA assay is inexpensive, rapid, and simple to perform and is of great value for the immediate
diagnosis of tuberculous pleuritis while waiting for culture result and this has a positive impact on patient outcome.
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Introduction
Tuberculous pleuritis occurs in about 25% of total tuberculosis
(TB) cases in South Africa [1,2]. Rapid diagnosis and prompt
treatment is needed to reverse the morbidity and mortality due to
TB. The diagnosis of tuberculous pleuritis remains a challenge
because of the small numbers of bacilli in the pleural fluid [3,4,5].
Pleural fluid staining for acid fast bacilli (AFB) and culture has low
sensitivity [4] and culture takes more than a week even when using
automated systems. Pleural biopsy culture and typical histology of
necrotizing granuloma is more sensitive than pleural fluid culture
[4]. However, the invasiveness of the procedure, inability to get
representative pleural tissue and the risk of complications are
limitations in obtaining pleural biopsies. We have recently
demonstrated that immunohistochemistry with the anti- MPT64
antibody as diagnostic tool offers a reasonable high sensitivity for
the diagnosis of TB pleuritis [6].
A well established biological marker for diagnosis of tuberculous
pleuritis is Adenosine Deaminase Activity (ADA) [4,7,8,9,10]. The
ADA assay principle is based on the detection of either hydrogen
peroxide or ammonia after enzymatic deamination of adenosine to
inosine by ADA. The unit cost of different commercial assays in
South Africa is about South African rands nine (equivalent to U.S
dollars 1.2). Production of the enzyme Adenosine Deaminase in
pleural fluid reflects the presence of activated T lymphocytes and
monocytes [11]. Therefore, it is expected that ADA will be lower
in HIV co-infected patients and/or other immunocompromised
patients with low blood CD4 counts. It has been shown that ADA
values correlate with CD4 counts in the pleural fluid of TB
patients [12]. Hsu et al [13] has shown lower sensitivity of ADA for
the diagnosis of TB pleural effusion in 10 immunocompromised
patients with chronic illness such as diabetes, cirrhosis, renal
failure and leukaemia. In contrast, Riantawan et al [14] did not
find any difference in the performance of ADA in 37 HIV positive
patients with mean CD4 counts above 100 cells/microL. A recent
study by Reuter et al [15] reported low sensitivity of ADA in
tuberculous pericarditis patients with advanced HIV disease and
median CD4 count of 59 (6–115) cells/microL. CD4 counts below
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50 are regarded as very low and are an indication for disease
progression [16]. However, it is not known how the ADA will
perform for the diagnosis of tuberculous pleuritis, a common
extra-pulmonary location in severely immunocompromised HIV
patients. The aim of this study was to evaluate the sensitivity of
ADA in tuberculous pleuritis patients with low CD4 counts and to
determine whether there was any correlation between CD4 cell
counts and ADA values.
Materials and Methods
Patients were identified through tracing of pleural fluid
specimens sent for culture to the microbiology laboratory at the
Dr George Mukhari (DGM) Hospital Ga-Rankuwa, Pretoria,
South Africa. All patients presenting with pleural effusion had
pleural tap and subsequently pleural fluid examination. Patients
were put on TB treatment after pleural tap if there was strong
suspicion of TB based on clinical features such as, history of
contact with TB patients, TB history, chronic cough, night sweats,
fever and loss of weight.
The diagnosis of TB pleuritis was confirmed if culture of
Mycobacterium tuberculosis in pleural fluid or tissue was positive or
there was caseous granuloma in the pleural biopsy and was
probable if; (1) there were clinical features such as history of TB
contact, past history of TB, chronic cough, night sweats, fever and
loss of weight; and (2) had clinical diagnosis of TB and started on
TB treatment in the absence of any other cause of effusion. The
control non- TB pleuritis group include; (1) malignant pleural
effusion confirmed by cytological examination of pleural fluid/
histological examination of pleural biopsy; (2) Pleural effusion of
other known etiology such as congestive cardiac failure or para-
pneumonic effusion. Cases without ADA results were excluded
from the analysis.
The clinical records of patients as described above for the period
January 2004 to January 2007 were reviewed. Data regarding
clinical presentation (cough, fever, chest pain, night sweats, loss of
weight, diarrhoea, oral thrush), acid fast staining (AFB) and culture
results of pleural fluid, HIV status, blood CD4 cell counts, and
biochemical parameters in pleural fluid (ADA, lactate dehydroge-
nase , total protein) were collected. The ADA was analysed using a
commercial colorimetric assay kit (Diazyme General Atomics,
CA). The cut-off value for positive ADA result was 30 U/L
according to clinical practice at this hospital [17]. The patients
were stratified according to the CD4 count as follows, ,50 and
.50, cells/microL as referred above [16].
The study was evaluated and approved by the Research, Ethics
and Publications Committee at the DGM Hospital, University of
Limpopo, South Africa and the Regional Committee for Ethics in
Medical Research in Bergen, Norway.
Statistical analysis
Data analysis was made by SPSS (SigmaStat; SPSS Inc;
Chicago, IL). Mean, correlation coefficient, and group comparison
was made with non parametric Mann-Whitney U test.
Results
A total of 300 pleural fluid samples were submitted to the
laboratory for the diagnosis of TB over the 3 year study period of
which 237 with available ADA results were included in the study.
There were 197 TB pleuritis patients: mean age 35 years with 107
females and 40 non-TB pleuritis patients: mean age 50 years with
19 females. Among the TB pleuritis patients, 72 were confirmed
TB pleuritis while the non-TB pleuritis included 26 malignancies
(adenocarcinoma, mesothelioma, squamous cell carcinoma, met-
astatic liver carcinoma, bronchial carcinoma and Kaposi sarco-
ma), 10 congestive cardiac failures, 2 hydrothorax, 1 Streptococcus
pneumoniae effusion and 1 Klebsiella pneumoniae empyema. The mean
ADA for each category is shown in Table 1. The ADA value was
positive, above the cut-off of 30 U/L in 186 of the 197 TB patients
giving a sensitivity of 94% (Table 2). The mean ADA value was
71.2U/L whilst the mean total protein value was 51 g/dl.
Among the 125 probable TB pleuritis patients; 89 were HIV
positive, 18 were HIV negative and HIV was not available for 18
patients. The median ADA values were 64 U/L and 58 U/L for
HIV positive and HIV negative respectively.
CD4 cell counts were available for 58 of the 72 patients among
the confirmed TB pleuritis patients. Fifty-one (88%) of the patients
with known CD4 cell counts were confirmed HIV positive,
whereas two were HIV negative with CD4 cell counts of 482 and
512 cells/microL. For five of the TB pleuritis patients the HIV was
not documented, but as the patients had CD4 cell counts in the
range of 19–208 cells/microL they were most likely HIV positive.
The ADA values with corresponding CD4 cell counts ,50 and
.50 cells/microL among confirmed TB pleuritis patients are
presented in table 3. The mean CD4 cell counts in the confirmed
TB pleuritis cases was 26 cells/microL in patients with CD4,50
cells/microL and 158 cells/microl in patients with CD4 count
Table 1. The mean ADA values in the different diagnostic
category.
Cases Mean ADA (U/L) 6SD
Malignancy* (N = 26) 12.9613.1
Congestive heart failure (N = 12) 7.1666.2
Streptococcus pneumoniae effusion (N = 1) 11
Klebsiella pneumoniae empyema (N= 1) 200
Total TB pleuritis (N = 197) 71.2639.6
SD= standard deviation;
*Kaposi sarcoma is the only malignancy with ADA of 73 above the cut-off.
doi:10.1371/journal.pone.0002788.t001
Table 2. Validity of ADA as a diagnostic test.
Cases Sensitivity % (CI) Specificity % (CI) PPV % (CI) NPV (%) (CI) LR+ (CI) LR2 (CI)
Confirmed TB pleuritis (n = 72) 94 (86–98) 95 (82–99) 97 (89–99) 90 (76–97) 18.9 (4.9–73 0.06 (0.02–0.15)
Clinical TB (n = 125) 94 (88–97) 95 (82–99) 98 (93–100) 84 (70–93) 18.9 (4.9–73.0) 0.06 (0.03–0.12)
Total TB Pleuritis (n = 197) 94 (90–97) 95 (82–99) 99 (96–100 77.5 (63–88) 18.9 (4.9–72.9) 0.06 (0.03–0.10)
PPV =positive predictive value; NPV= negative predictive value; CI = 95% confidence interval; LR+=positive likelihood ratio; LR2=negative likelihood ratio.
doi:10.1371/journal.pone.0002788.t002
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.50 cells/microL, (p,0.05) and the corresponding values among
total TB cases was 29 and153 (p,0.05) respectively.
The sensitivity and specificity of ADA was 94% and 95%
respectively as shown in table 2. The positive and negative
likelihood ratio was 19 and 0.06 respectively. The mean ADA
values for the different categories is shown in table 3. The mean
ADA value was highest in tuberculous pleuritis except for Kaposi
sarcoma, and empyema in which the ADA gave false positive
result. The sensitivity of ADA was not affected by low CD4 cell
count. In addition, there was no significant difference in the mean
ADA value in patients with lower CD4 counts (81 U/L655.1); (76
U/L645.3) compared to those with higher CD4 cell counts (70
U/L637.8); (72 U/L640.6), (p.0.5) among confirmed and total
TB pleuritis respectively. The four patients with CD4 cell counts of
less than 10 cells/microL (1, 2, 4, and 7 cells/microL) among
confirmed TB pleuritis patients had ADA values above the cut-off
with values of 46, 55, 41, and 86 U/L, respectively (Table 3).
There was no correlation between ADA values and blood CD4
cell counts (Figure 1).
There was no statistical difference in the absolute blood
lymphocyte count; pleural fluid lymphocytes number or percent-
age, lactate dehydrogenase and total protein between patients with
CD4 cell counts ,50 and .50 cells/microL when group
comparison was made with non parametric Mann-Whitney U
test (Table 4).
Furthermore there was no correlation between ADA values and
blood CD4 counts, absolute lymphocyte count and red cell counts
in blood or lymphocyte counts and percentage, lactate dehydro-
genase and total protein in pleural fluid (Table 5).
Discussion
We have evaluated the usefulness of the ADA assay in
predominantly HIV positive patients with very low CD4 counts.
The overall sensitivity of the ADA assay in diagnosing tuberculous
pleuritis was 94%. This finding is similar to that reported in a
number of studies [12,14,18,19,20]. However this is the first study
demonstrating high sensitivity of the ADA assay in HIV patients
with very low CD4 cell counts. As shown in our study there was no
significant difference in sensitivity when comparing cases with
CD4 cell counts of less than 50 cells/microL to those with CD4
counts greater than 50 cells/microL. In fact, the mean ADA value
was higher in the group with the lower CD4 cell count.
The ADA is useful for the diagnosis of TB pleuritis since the
result is available on the same day compared to culture which
takes about 2 weeks. This allows for rapid institution of TB
treatment leading to improvement in patient outcome[21].
Furthermore the positive likelihood ratio (LR) was .10 and the
negative likelihood ratio was ,0.1, this implies that the ADA is
useful in clinical practice to rule in and rule out TB pleuritis. The
advantage of LR is that it is not affected by prevalence of disease as
opposed to positive predictive value.
Previous studies evaluating the usefulness of ADA for the
diagnosis of tuberculous pleuritis have either a very small number
of HIV positive cases [22] or patients with higher mean CD4
counts [14]. Hsu et al [13] have shown a low sensitivity for ADA in
tuberculous pleural effusion in immunocompromised chronic
diseases patients, however only 10 patients were evaluated and
the HIV status was not determined. Corral et al [23] reported a
similar low sensitivity in HIV positive tuberculous meningitis cases
whilst Reuter et al [15] reported low sensitivity of ADA in
tuberculous pericarditis patients with advanced HIV disease
compared to cases with higher CD4 cell count. The difference
in the outcome of our retrospective study compared with that of
Reuter et al may be due to the fact that majority of the patients in
this study had lower CD4 cell counts.
Different cut-off values ranging from10 to 71 U/L have been
used for positive ADA test, but the type of ADA assays has not
shown any variations in sensitivity [24]. The cut-off value of 30 U/
L for tuberculous pleuritis as used in this study is expected to offer
a specificity of 98% [17] and is used in the clinical setting at our
institution and by most laboratories in South Africa.
We did not find any correlation between the ADA values and
CD4 cell counts. Even at CD4 counts of less than 10cells/microL,
the ADA values were still above the cut-off. We also did not find
any correlation between ADA values and CD4 cell counts in
another cohort of South African HIV infected TB pleuritis
Table 3. HIV status, CD4 counts and ADA values for the 2
groups with ,50 (N = 25) and .50 (N = 33) CD4 counts
among confirmed TB pleuritis patients.
CD4,50 cells/microL CD4 .50 cells/microL
Case HIV CD4 ADA HIV CD4 ADA
1 pos 1 46 1 pos 55 38
2 pos 2 55 2 pos 55 60
3 pos 4 41 3 pos 57 60
4 pos 7 86 4 pos 60 112
5 pos 13 4 5 pos 64 112
6 pos 12 98 6 NA 65 61
7 pos 15 200 7 pos 66 133
8 pos 18 21 8 pos 66 51
9 pos 19 42 9 pos 70 36
10 pos 19 210 10 pos 74 112
11 NA 19 55 11 pos 75 73
12 pos 20 71 12 pos 77 43
13 pos 30 52 13 pos 79 53
14 pos 32 56 14 pos 80 186
15 pos 33 51 15 pos 80 38
16 NA 33 55 16 pos 105 1
17 pos 35 132 17 pos 115 88
18 pos 38 124 18 pos 121 44
19 pos 40 48 19 pos 132 53
20 pos 40 112 20 pos 163 64
21 pos 40 93 21 pos 168 35
22 pos 41 70 22 pos 179 44
23 pos 43 200 23 NA 180 38
24 pos 45 71 24 pos 200 107
25 pos 46 32 25 pos 200 49
26 NA 208 67
27 pos 229 96
28 pos 241 113
29 pos 251 102
30 pos 302 100
31 pos 401 35
32 neg 482 70
33 neg 512 28
pos =positive, neg= negative, NA= not available, ADA= adenosine deaminase.
doi:10.1371/journal.pone.0002788.t003
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patients [25]. This may be due to higher immune activation in
HIV positive patients with very low CD4 counts [26]. Further-
more, we did not find any correlation between ADA values and
pleural fluid lymphocyte numbers or percentage in agreement with
the study by Lee et al [27], but in contrast to other studies [12,28].
One explanation could be that the isoenzyme ADA-2 which
contributes significantly to total ADA in diagnosing TPE is found
mainly in the monocytes [29] which are not significantly affected
in HIV patients compared to CD4 T-lymphocytes.
Interferon gamma is considered to be a better marker than
ADA for the diagnosis of tuberculous pleuritis, since its estimation
is not affected by immununosuppression [30,31]. However, in our
study the ADA assay performed well even at very low CD4 count
below 10 cells/microL and the cost of estimating ADA is 20 times
less than that of interferon gamma estimation. Therefore ADA
analysis is more cost effective than the estimation of interferon
gamma for the diagnosis of tuberculous pleuritis in developing
countries [18].
We have shown that ADA offers a high sensitivity and is rapid
for the diagnosis of tuberculous pleuritis in HIV patients with low
Figure 1. Correlation plot of ADA in pleural fluid and blood CD4 counts in TB pleuritis patients (N=129).
doi:10.1371/journal.pone.0002788.g001
Table 4. Group comparison of laboratory markers among
total TB pleuritis patients with ,50 (N = 41) and .50 (N = 88)
CD4 counts.
Laboratory test (N)
Mann-Whitney
U values p- values
In pleural fluid
Adenosine deaminase U/L (129) 1725.5 0.691
Lymphocyte cells/microL (86) 586.0 0.060
Lymphocyte % (68) 401.5 0.216
Lactate dehydro-genase U/L (115) 1315.0 0.325
Total protein g/L (105) 1211 0.925
In blood
CD4 count cells/microL (129) ,0.05* ,0.05*
Absolute Lymphocyte count X109/L (75) 552.0 0.181
Red blood cells X 1012/L (111) 1044.5 0.054
* = significant difference between the 2 groups.
doi:10.1371/journal.pone.0002788.t004
Table 5. Correlation (r) values for ADA and other blood and
pleural fluid markers in tuberculous pleuritis patients
(N= 197).
Test r p-values
In blood
CD4 counts cells/microL 20.14 0.114
Absolute blood lymphocytes x 10 9/L 20.049 0.667
Red blood cells x 1012/L 20.044 0.644
In pleural fluid
Leucocytes 0.028 0.798
LYM% 0.110 0.373
Lactate dehydro-genase U/L 0.152 0.104
Total protein g/L 0.045 0.649
LYM%=pleural fluid lymphocyte percentage of total leucocytes.
doi:10.1371/journal.pone.0002788.t005
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CD4 counts in a high TB endemic region. This is an important
finding for countries with high burden of TB and HIV co-
infection. Furthermore ADA is inexpensive, rapid, and simple to
perform and is of great value in the diagnosis of tuberculous
pleuritis for early institution of TB treatment.
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